A first-ever large-scale national study has been launched to evaluate the effectiveness of buprenorphine/naloxone, marketed as Suboxone, in the treatment of addiction to prescription opioid painkillers such as Vicodin and OxyContin. Suboxone is used to help opiate addicts through withdrawal and drug detox programs. The research is funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. NIDA's National Drug Abuse Treatment Clinical Trials Network (CTN) is conducting the multi-site study, known as the Prescription Opiate Addiction Treatment Study (POATS). The study is being carried out at NYU Medical Center in partnership with Bellevue Hospital Center, as well as at 10 other sites across the country. Several study sites are in View the rest of this article
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment